Parodi H C, Colombato L O, Gutiérrez S, Lattanzi M
Department of Gastroenterology, Hospital Nacional Dr. Alejandro Posadas, Haedo, Buenos Aires, Argentina.
Acta Gastroenterol Latinoam. 1989;19(3):123-9.
The aim of this study was to investigate the usefulness of lipase and isoamylases in the diagnosis of acute pancreatitis and to determine if its use permits differential diagnosis between acute pancreatitis and acute biliary tract disease. Three groups of patients were studied. a)
60 patients without abdominal diseases. b) Acute pancreatitis: 60 patients, the diagnosis was made according to clinical symptoms, biochemical tests, U.S. and C.T. in 24 (40%), in the remainder 36 (60%) surgical confirmation was obtained. c) Acute biliary tract disease without macroscopic pancreatic damage, 30 patients, the diagnosis was made according to biochemical tests and U.S. in 4 (13.3%) whereas in the remainder 26 (86.6%) surgical confirmation was accomplished no later than a week of the beginning of the symptoms. Biochemical tests: serum and urine amylase, lipase, and total pancreatic and salivary isoamylases were evaluated. In the group of acute pancreatitis the highest diagnostic sensibility was: pancreatic isoamylase 95.5%, lipase 95%, total serum amylase 93.3% urine amylase 90%, serum amylase 78.3%. In acute biliary tract diseases a high number of elevated enzyme values were also found: pancreatic isoamylase 83.3%, total isoamylase 73.3%, urine amylase 66.6%, lipase 63.3%, serum amylase 53.3%. The mean enzyme values of both groups were compared statistically and showed no significant difference. We conclude that lipase and isoamylases are the best markers for the diagnosis of acute pancreatitis and the differential diagnosis with acute biliary diseases is difficult because an elevation of these enzymes is a characteristic shared by both pathologies. The diagnosis of acute pancreatitis based only in clinical symptoms and hyperamylasemia can be erroneous.
本研究的目的是探讨脂肪酶和异淀粉酶在急性胰腺炎诊断中的作用,并确定其使用是否有助于急性胰腺炎与急性胆道疾病的鉴别诊断。研究了三组患者。a)对照组:60例无腹部疾病的患者。b)急性胰腺炎组:60例患者,根据临床症状、生化检查、超声和CT确诊,其中24例(40%)通过这些检查确诊,其余36例(60%)经手术证实。c)无胰腺宏观损伤的急性胆道疾病组,30例患者,4例(13.3%)根据生化检查和超声确诊,其余26例(86.6%)在症状出现后一周内通过手术证实。生化检查:评估血清和尿液淀粉酶、脂肪酶以及总胰腺和唾液异淀粉酶。在急性胰腺炎组中,最高诊断敏感性为:胰腺异淀粉酶95.5%,脂肪酶95%,血清总淀粉酶93.3%,尿淀粉酶90%,血清淀粉酶78.3%。在急性胆道疾病组中也发现大量酶值升高:胰腺异淀粉酶83.3%,总异淀粉酶73.3%,尿淀粉酶66.6%,脂肪酶63.3%,血清淀粉酶53.3%。对两组的平均酶值进行统计学比较,未发现显著差异。我们得出结论,脂肪酶和异淀粉酶是诊断急性胰腺炎的最佳标志物,与急性胆道疾病的鉴别诊断困难,因为这些酶的升高是两种疾病共有的特征。仅基于临床症状和高淀粉酶血症诊断急性胰腺炎可能有误。